Johnson & Johnson (JNJ)

Return on equity (ROE)

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net income	US$ in thousands	35,153,000	17,941,000	20,878,000	14,714,000	15,119,000
Total stockholders’ equity	US$ in thousands	68,774,000	76,804,000	74,023,000	63,278,000	59,471,000
ROE		51.11%	23.36%	28.20%	23.25%	25.42%

December 31, 2023 calculation

ROE = Net income ÷ Total stockholders’ equity
= $35,153,000K ÷ $68,774,000K
= 51.11%

Johnson & Johnson's return on equity (ROE) has shown a positive trend over the past five years, increasing from 25.42% in December 2019 to 51.11% in December 2023. This indicates the company's ability to generate profit from shareholders' equity has significantly improved. The substantial rise in ROE reflects efficient utilization of equity capital to generate income for shareholders. Overall, Johnson & Johnson's ROE performance demonstrates strong financial health and efficient management of its assets and liabilities to enhance shareholder value.